drugset / Trial / NCT00003060

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

NCT00003060

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study the effectiveness of chemotherapy plus bone marrow transplantation in treating patients with metastatic melanoma that has not responded to previous therapy.

Timeline

Start
1995-03
Primary completion
2001-02-22
Completion
2001-02-22

Drugs

EvaluationDrugModalityDoseRoute
Background Busulfan Small molecule Oral
Background Cyclophosphamide Other / unclassified Intravenous
Background Cyclosporine Peptide
Background Methotrexate Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Intravenous

Indications